The company has successfully developed a series of in vitro detection products of "cancer liquid gene detection" with completely independent intellectual property rights
Number of views：
The company has successfully developed a series of in vitro detection products of "cancer liquid gene detection" with completely independent intellectual property rights, which are applied to the determination of circulating tumor DNA (ctDNA) with the unique technology of adding molecular barcode, so as to
Prev：Never forget the original intention and forge ahead
Next：nothing...
